AU468904B2 - New 2-amino-4 h-pyrane compounds, their production, and their medicinal use - Google Patents

New 2-amino-4 h-pyrane compounds, their production, and their medicinal use

Info

Publication number
AU468904B2
AU468904B2 AU58258/73A AU5825873A AU468904B2 AU 468904 B2 AU468904 B2 AU 468904B2 AU 58258/73 A AU58258/73 A AU 58258/73A AU 5825873 A AU5825873 A AU 5825873A AU 468904 B2 AU468904 B2 AU 468904B2
Authority
AU
Australia
Prior art keywords
amino
new
production
medicinal use
pyrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU58258/73A
Other languages
English (en)
Other versions
AU5825873A (en
Inventor
Meyer Friedrich Bossert Wulf Vater Kurt Stoppel Horst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU5825873A publication Critical patent/AU5825873A/en
Application granted granted Critical
Publication of AU468904B2 publication Critical patent/AU468904B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/20—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D309/22—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU58258/73A 1972-07-19 1973-07-18 New 2-amino-4 h-pyrane compounds, their production, and their medicinal use Expired AU468904B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEDE82235 1972-07-19
DE2235406A DE2235406C3 (de) 1972-07-19 1972-07-19 2-Amino-4H-pyrane, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Publications (2)

Publication Number Publication Date
AU5825873A AU5825873A (en) 1975-01-23
AU468904B2 true AU468904B2 (en) 1976-01-29

Family

ID=5851048

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58258/73A Expired AU468904B2 (en) 1972-07-19 1973-07-18 New 2-amino-4 h-pyrane compounds, their production, and their medicinal use

Country Status (27)

Country Link
US (1) US3897462A (OSRAM)
JP (2) JPS596873B2 (OSRAM)
AT (3) AT328443B (OSRAM)
AU (1) AU468904B2 (OSRAM)
BE (1) BE802496A (OSRAM)
BG (1) BG22828A3 (OSRAM)
CA (1) CA999299A (OSRAM)
CH (1) CH597216A5 (OSRAM)
CS (2) CS174245B2 (OSRAM)
DD (1) DD109381A5 (OSRAM)
DE (1) DE2235406C3 (OSRAM)
DK (1) DK132410C (OSRAM)
ES (2) ES416988A1 (OSRAM)
FI (1) FI58498C (OSRAM)
FR (1) FR2192842B1 (OSRAM)
GB (1) GB1402793A (OSRAM)
HU (1) HU166811B (OSRAM)
IE (1) IE38064B1 (OSRAM)
IL (1) IL42745A (OSRAM)
LU (1) LU68031A1 (OSRAM)
NL (1) NL7309889A (OSRAM)
NO (2) NO138656C (OSRAM)
PL (2) PL90876B1 (OSRAM)
RO (2) RO63583A (OSRAM)
SE (1) SE399259B (OSRAM)
SU (1) SU466682A3 (OSRAM)
ZA (1) ZA734890B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5919019U (ja) * 1982-07-29 1984-02-04 株式会社吉野工業所 化粧品容器
DE4429786A1 (de) * 1994-08-23 1996-02-29 Bayer Ag Verwendung von substituierten 6-Amino-4H-pyranen
DE19529858A1 (de) * 1995-08-14 1997-02-20 Bayer Ag Substituierte 4H-Pyrane
DE19529859A1 (de) * 1995-08-14 1997-02-20 Bayer Ag Verwendung von Acyl-substituierten Aminopyranen

Also Published As

Publication number Publication date
US3897462A (en) 1975-07-29
ZA734890B (en) 1974-06-26
DK132410C (da) 1976-05-03
ES442696A1 (es) 1977-04-16
IE38064B1 (en) 1977-12-21
SE399259B (sv) 1978-02-06
FI58498B (fi) 1980-10-31
DK132410B (da) 1975-12-01
PL90876B1 (OSRAM) 1977-02-28
HU166811B (OSRAM) 1975-06-28
SU466682A3 (ru) 1975-04-05
CH597216A5 (OSRAM) 1978-03-31
BE802496A (fr) 1974-01-18
IE38064L (en) 1974-01-19
CA999299A (en) 1976-11-02
FR2192842A1 (OSRAM) 1974-02-15
DE2235406A1 (de) 1974-02-07
IL42745A (en) 1976-12-31
NO138656B (no) 1978-07-10
NO138656C (no) 1978-10-18
RO62811A (fr) 1977-11-15
DE2235406B2 (de) 1981-01-22
AU5825873A (en) 1975-01-23
LU68031A1 (OSRAM) 1973-09-17
FI58498C (fi) 1981-02-10
PL95715B1 (pl) 1977-11-30
ATA638873A (de) 1975-03-15
DE2235406C3 (de) 1982-01-07
GB1402793A (en) 1975-08-13
FR2192842B1 (OSRAM) 1977-07-15
JPS56108784A (en) 1981-08-28
RO63583A (fr) 1978-08-15
NO772996L (no) 1974-01-22
JPS597714B2 (ja) 1984-02-20
JPS596873B2 (ja) 1984-02-15
JPS4955670A (OSRAM) 1974-05-30
BG22828A3 (bg) 1977-04-20
CS174214B2 (OSRAM) 1977-03-31
CS174245B2 (OSRAM) 1977-03-31
IL42745A0 (en) 1973-10-25
DD109381A5 (OSRAM) 1974-11-05
NO139440C (no) 1979-03-14
AT328443B (de) 1976-03-25
NO139440B (no) 1978-12-04
NL7309889A (OSRAM) 1974-01-22
ES416988A1 (es) 1976-06-01
AT326653B (de) 1975-12-29
ATA19475A (de) 1975-06-15

Similar Documents

Publication Publication Date Title
AU462239B2 (en) New phenyl-imidazolyl-alkanyl derivatives, their production and their pharmaceutical use
AU476126B2 (en) New triazine derivatives, their production and their medicinal use
ZA731504B (en) New bridgehead-heterocyclic compounds,their production and their medicinal use
ZA73702B (en) New heterocyclic compounds,their production and their medicinal use
AU470790B2 (en) New 2-amino-1, 4-dihydropyridines, their production, and their medicinal use
AU471621B2 (en) New 1-ethyl-imidazoles, their production, and their medicinal use
AU469267B2 (en) New 2-alkylamino-dihydropyridines, their production and their medicinal use
AU476464B2 (en) New penicillins, their production and their pharmaceutical use
AU5825873A (en) New 2-amino-4 h-pyrane compounds, their production, and their medicinal use
AU476373B2 (en) New 3, 4-dihydropyridones, their production, and their medicinal use
AU475884B2 (en) New amidophenylisothioureas, their production, and their medicinal use
AU475701B2 (en) Phenylguanidine derivatives, their production and their medicinal use
AU476612B2 (en) New benzoylphenylisothioureas, their production, and their medicinal use
AU474624B2 (en) New bridgehead-heterocyclic compounds, their production and their medicinal use
CA907605A (en) Azo compounds, their production and use
AU481122B2 (en) new ACYLAMINO-PHENYL-ACETAMIDINE COMPOUNDS THEIR PRODUCTION, AND THEIR MEDICINAL USE
AU476155B2 (en) New 2, 6-diamino-dihydropyridines, their production and their medicinal use
CA913096A (en) Quinazolone derivatives, their production and their medicinal use
AU7338474A (en) new ACYLAMINO-PHENYL-ACETAMIDINE COMPOUNDS THEIR PRODUCTION, AND THEIR MEDICINAL USE
AU485457B2 (en) New penicillin compounds, their production, and their medicinal use
AU448290B2 (en) New aminophenylamidines, their production and their medicinal use
CA893115A (en) Azo compounds, their production and use
CA907607A (en) Azo compounds, their production and use
CA914673A (en) Azo compounds, their production and use
CA914160A (en) Azo compounds, their production and use